Partners & Collaborators

There are over 160 proteins that misfold and cause disease in the body, including in many rare indications as well as in major diseases (cancer, diabetes). The Treventis team is exploring the use of CCM for designing drugs in these indications and welcomes inquiries for specific collaborations or partnerships in protein misfolding disorders. Please contact us for more information.

Treventis has a partnered program in Alzheimer’s disease with Takeda Pharmaceutical Company and two currently funded awards from the U.S. Department of Defense.

 Treventis further recognizes collaboration and support from the following organizations: